Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.09 USD | -2.05% | +0.33% | +7.70% |
Mar. 18 | Voyager Therapeutics, Inc.(NasdaqGS:VYGR) added to S&P Biotechnology Select Industry Index | CI |
Mar. 13 | Voyager Therapeutics Appoints Toby Ferguson as Chief Medical Officer | MT |
Financials (USD)
Sales 2024 * | 36.62M | Sales 2025 * | 46.8M | Capitalization | 494M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -112M | EV / Sales 2024 * | 4.84 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 * |
-4.89
x | P/E ratio 2025 * |
-4.81
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.69% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | -2.05% | ||
1 week | -2.99% | ||
Current month | +9.25% | ||
1 month | +20.40% | ||
3 months | +13.91% | ||
6 months | +14.20% | ||
Current year | +7.70% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 75 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 36 M€ | +2.98% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 9.09 | -2.05% | 764,131 |
24-03-15 | 9.28 | +1.64% | 3,891,945 |
24-03-14 | 9.13 | -0.11% | 461,668 |
24-03-13 | 9.14 | +0.55% | 535,334 |
24-03-12 | 9.09 | +0.33% | 669,381 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.70% | 504M | |
+9.72% | 46B | |
+35.14% | 39.85B | |
+4.84% | 39.76B | |
-9.43% | 28.16B | |
+17.47% | 27.62B | |
-22.99% | 18.8B | |
+10.88% | 13.3B | |
+27.53% | 12.2B | |
-6.84% | 11.4B |